Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Microsoft
MSFT
|
+$7.54B |
| 2 |
Apple
AAPL
|
+$5.11B |
| 3 |
Amazon
AMZN
|
+$2.93B |
| 4 |
UnitedHealth
UNH
|
+$2.83B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$2.75B |
Top Sells
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$330M |
| 2 |
Snap
SNAP
|
+$321M |
| 3 |
Twilio
TWLO
|
+$309M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$156M |
| 5 |
AVLR
Avalara, Inc.
AVLR
|
+$154M |
Sector Composition
| 1 | Technology | 29.71% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTXS
651
DELISTED
Citrix Systems Inc
CTXS
| $22.1M | 0.01% |
213,112
+125,910
| +144% | +$13.1M |
|
652
Corcept Therapeutics
CORT
$7.55B
| $21.9M | 0.01% |
854,326
+701,815
| +460% | +$18M |
|
653
Yeti Holdings
YETI
$2.88B
| $21.8M | 0.01% |
763,558
+737,029
| +2,778% | +$21M |
|
654
ZimVie
ZIMV
$532M
| $21.5M | 0.01% |
2,181,712
+1,059,733
| +94% | +$10.5M |
|
655
Health Catalyst
HCAT
$229M
| $21.5M | 0.01% |
2,218,438
+992,197
| +81% | +$9.62M |
|
656
Medpace
MEDP
$13.4B
| $21.3M | 0.01% |
135,396
+114,905
| +561% | +$18.1M |
|
657
4D Molecular Therapeutics
FDMT
$324M
| $21.2M | 0.01% |
2,639,462
+1,304,414
| +98% | +$10.5M |
|
|
KVSC
658
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $21.2M | 0.01% |
2,170,722
+1,970,387
| +984% | +$19.3M |
|
659
Fidelity National Financial
FNF
$16.2B
| $21.2M | 0.01% |
609,282
+390,820
| +179% | +$13.6M |
|
|
ITCI
660
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $21.1M | 0.01% |
453,482
+265,431
| +141% | +$12.3M |
|
661
HDFC Bank
HDB
$180B
| $21.1M | 0.01% |
360,580
+170,676
| +90% | +$9.98M |
|
662
West Fraser Timber
WFG
$5.84B
| $21M | 0.01% |
288,200
+102,359
| +55% | +$7.45M |
|
663
Expensify
EXFY
$174M
| $20.9M | 0.01% |
1,407,804
+703,902
| +100% | +$10.5M |
|
664
Phreesia
PHR
$1.52B
| $20.9M | 0.01% |
821,174
+410,593
| +100% | +$10.5M |
|
665
Consolidated Edison
ED
$35B
| $20.9M | 0.01% |
243,280
+157,728
| +184% | +$13.5M |
|
666
First American
FAF
$6.74B
| $20.8M | 0.01% |
450,066
+139,786
| +45% | +$6.44M |
|
667
MGIC Investment
MTG
$6.54B
| $20.7M | 0.01% |
1,615,330
-1,874,877
| -54% | -$24M |
|
668
Dominion Energy
D
$50.7B
| $20.4M | 0.01% |
294,774
+118,547
| +67% | +$8.2M |
|
|
Y
669
DELISTED
Alleghany Corporation
Y
| $20.3M | 0.01% |
24,206
+13,602
| +128% | +$11.4M |
|
670
IDEAYA Biosciences
IDYA
$2.17B
| $20.3M | 0.01% |
1,362,354
+1,066,187
| +360% | +$15.9M |
|
671
FormFactor
FORM
$2.27B
| $20.3M | 0.01% |
810,876
+248,385
| +44% | +$6.22M |
|
|
VIVO
672
DELISTED
Meridian Bioscience Inc
VIVO
| $20.1M | 0.01% |
637,802
+592,913
| +1,321% | +$18.7M |
|
673
Cigna
CI
$80.7B
| $20.1M | 0.01% |
72,250
+33,325
| +86% | +$9.26M |
|
|
STOR
674
DELISTED
STORE Capital Corporation
STOR
| $20M | 0.01% |
639,744
+442,031
| +224% | +$13.8M |
|
675
Blackrock
BLK
$171B
| $20M | 0.01% |
36,352
+16,983
| +88% | +$9.35M |
|